Prepare for your visit
Aaron Brown
Psychiatry · Mckinney, TX · NPI 1023455649
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$870.30
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Neurocrine Biosciences, INC. $244.12
- Acadia Pharmaceuticals INC $235.64
- Teva Pharmaceuticals USA, INC. $232.62
- Axonics, INC. $116.50
- Boston Scientific Corporation $26.19
- Sunovion Pharmaceuticals INC. $15.23
Drugs and devices associated with these payments
Nuplazid Ingrezza Axonics Austedo Xr
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Aaron Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1019114/aaron-brown